The initial public offer (IPO) of Aakaar Medical Technologies received bids for 9,23,200 shares as against 26,83,200 shares on offer, as per NSE data as of 17:00 hours on Friday (20 June 2025). The issue was subscribed 0.34 times.
The issue opened for bidding on Friday (20 June 2025) and it will close on Tuesday (24 June 2025). The price band of the IPO is fixed between Rs 68 to Rs 72 per share. The minimum order quantity is 1,600 equity shares. The equity shares will list on NSE’s SME platform.
The IPO comprises fresh issue of 37,50,400 equity shares. About 1,88,800 equity shares will be reserved for subscription by market maker to the issue. The net issue comprises of 35,61,600 equity shares including anchor allocation portion.
The issue and the net issue will constitute 26.46% and 25.13%, respectively of the post issue paid up equity share capital of the company.
The company intends to utilize the net proceeds for funding working capital requirements of the company and general corporate purpose.
Ahead of the Aakaar Medical Technologies on Thursday, 19 June 2025, raised Rs 7.68 crore from anchor investors. The board has allotted 10.67 lakh shares at Rs 72 per share to 5 anchor investors.
Aakaar Medical Technologies is a medical aesthetics company engaged in offering a wide range of aesthetic and specialized cosmetic products and devices. Its product portfolio includes both own brands—domestically manufactured through loan licensing or third-party manufacturers—and the distribution of products and devices from imported brands. The company primarily supplies its products and devices to aesthetic physicians such as dermatologists, plastic surgeons, and aesthetic physicians, who in turn sell these products to end consumers and use certain device consumables as part of their treatments. As of 30 May 2025, the company had total 177 employees.
The company recorded revenue from operations of Rs 61.58 crore and net profit of Rs 6.04 crore for the period ended 31 March 2025.